Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

Author： Samtani Mahesh N.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.48, Iss.9, 2009-09, pp. : 585-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia

By Alphs Larry   Bossie Cynthia A   Fu Dong-Jing   Ma Yi-Wen   Kern Sliwa Jennifer  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1029-1042

Informa Healthcare

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H.   Chouinard G.   Margolese H.C.  

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

The Pharmacokinetics of Long-Acting Antipsychotic Medications

By  

Current Clinical Pharmacology, Vol. 9, Iss. 3, 2014-08 ,pp. : 310-317

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 270-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intramuscular Paliperidone Palmitate

By Hoy Sheridan M.   Scott Lesley J.   Keating Gillian M.  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 227-244

Adis International

Access to resources Recommend Favorite